Scott Long

Array ( [id] => 4950027 [patent_doc_number] => 20080306153 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'Lipids and lipid assemblies comprising transfection enhancer elements' [patent_app_type] => utility [patent_app_number] => 12/004154 [patent_app_country] => US [patent_app_date] => 2007-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 33595 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20080306153.pdf [firstpage_image] =>[orig_patent_app_number] => 12004154 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5272150 [patent_doc_number] => 20090075926 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'METHOD FOR IDENTIFYING AND MANIPULATING CELLS' [patent_app_type] => utility [patent_app_number] => 11/951613 [patent_app_country] => US [patent_app_date] => 2007-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 33324 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20090075926.pdf [firstpage_image] =>[orig_patent_app_number] => 11951613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5278079 [patent_doc_number] => 20090130211 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'Gelled colloidal emulsion for appetite suppression' [patent_app_type] => utility [patent_app_number] => 11/984341 [patent_app_country] => US [patent_app_date] => 2007-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6710 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20090130211.pdf [firstpage_image] =>[orig_patent_app_number] => 11984341 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9112603 [patent_doc_number] => 08568771 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-29 [patent_title] => 'Use of microvesicles (MVs) derived from stem cells for preparing a medicament for endo/epithellal regeneration of damaged or injured tissues or organs, and related in vitro and in vivo methods' [patent_app_type] => utility [patent_app_number] => 12/734396 [patent_app_country] => US [patent_app_date] => 2007-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 20 [patent_no_of_words] => 9310 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12734396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8397975 [patent_doc_number] => 08268347 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2012-09-18 [patent_title] => 'Dual action, inhaled formulations providing both an immediate and sustained release profile' [patent_app_type] => utility [patent_app_number] => 11/876539 [patent_app_country] => US [patent_app_date] => 2007-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12537 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11876539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4903525 [patent_doc_number] => 20080112938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'RECOMBINANT EUKARYOTIC CELLS STABLY EXPRESSING (SID-1) PROTEINS FOR HIGH THROUGHPUT GENE SCREENING' [patent_app_type] => utility [patent_app_number] => 11/864435 [patent_app_country] => US [patent_app_date] => 2007-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14449 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20080112938.pdf [firstpage_image] =>[orig_patent_app_number] => 11864435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4704568 [patent_doc_number] => 20080064092 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-13 [patent_title] => 'FUSION PROTEINS' [patent_app_type] => utility [patent_app_number] => 11/853517 [patent_app_country] => US [patent_app_date] => 2007-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12577 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20080064092.pdf [firstpage_image] =>[orig_patent_app_number] => 11853517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5977481 [patent_doc_number] => 20110154515 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'GENETICALLY ENCODED CALCIUM SENSORS COMPRISING THE C-TERMINAL LOBE OF TROPONIN C AND A FLUORESCENCE TAG' [patent_app_type] => utility [patent_app_number] => 12/675025 [patent_app_country] => US [patent_app_date] => 2007-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19278 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20110154515.pdf [firstpage_image] =>[orig_patent_app_number] => 12675025 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6343572 [patent_doc_number] => 20100330105 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'Anticancer Combination Therapies' [patent_app_type] => utility [patent_app_number] => 12/438300 [patent_app_country] => US [patent_app_date] => 2007-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 45877 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0330/20100330105.pdf [firstpage_image] =>[orig_patent_app_number] => 12438300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5446110 [patent_doc_number] => 20090047336 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => ' NOVEL FORMULATION OF DEHYDRATED LIPID VESICLES FOR CONTROLLED RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENT VIA INHALATION' [patent_app_type] => utility [patent_app_number] => 11/840537 [patent_app_country] => US [patent_app_date] => 2007-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8848 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20090047336.pdf [firstpage_image] =>[orig_patent_app_number] => 11840537 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4892986 [patent_doc_number] => 20080102084 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-01 [patent_title] => 'Anti-cancer DNA Vaccine Employing Plasmids Encoding Mutant Oncoprotein Antigen and Calreticulin' [patent_app_type] => utility [patent_app_number] => 11/828807 [patent_app_country] => US [patent_app_date] => 2007-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 27754 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20080102084.pdf [firstpage_image] =>[orig_patent_app_number] => 11828807 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4915610 [patent_doc_number] => 20080096210 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-24 [patent_title] => 'Cancer suppressing agent' [patent_app_type] => utility [patent_app_number] => 11/878559 [patent_app_country] => US [patent_app_date] => 2007-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10174 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20080096210.pdf [firstpage_image] =>[orig_patent_app_number] => 11878559 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5570404 [patent_doc_number] => 20090253782 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'Compounds for Enhancing Arginase Activity and Methods of USe Thereof' [patent_app_type] => utility [patent_app_number] => 12/309500 [patent_app_country] => US [patent_app_date] => 2007-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 9987 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20090253782.pdf [firstpage_image] =>[orig_patent_app_number] => 12309500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4734383 [patent_doc_number] => 20080051363 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-28 [patent_title] => 'G-rich polynucleotides as a novel therapeutic for the treatment of huntington\'s disease' [patent_app_type] => utility [patent_app_number] => 11/879190 [patent_app_country] => US [patent_app_date] => 2007-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 21091 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20080051363.pdf [firstpage_image] =>[orig_patent_app_number] => 11879190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5265533 [patent_doc_number] => 20090118218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'Biocompatible Hydrogels' [patent_app_type] => utility [patent_app_number] => 12/298602 [patent_app_country] => US [patent_app_date] => 2007-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4865 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20090118218.pdf [firstpage_image] =>[orig_patent_app_number] => 12298602 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6220589 [patent_doc_number] => 20100055684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'COMPOSITION FOR NUCLEIC ACID TRANSFECTION' [patent_app_type] => utility [patent_app_number] => 12/306993 [patent_app_country] => US [patent_app_date] => 2007-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14305 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20100055684.pdf [firstpage_image] =>[orig_patent_app_number] => 12306993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4495155 [patent_doc_number] => 07947478 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-24 [patent_title] => 'Short chain volatile hydrocarbon production using genetically engineered microalgae, cyanobacteria or bacteria' [patent_app_type] => utility [patent_app_number] => 11/770412 [patent_app_country] => US [patent_app_date] => 2007-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 15 [patent_no_of_words] => 12303 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/947/07947478.pdf [firstpage_image] =>[orig_patent_app_number] => 11770412 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4853140 [patent_doc_number] => 20080318883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'Anti-aging supplement' [patent_app_type] => utility [patent_app_number] => 11/812455 [patent_app_country] => US [patent_app_date] => 2007-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3583 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20080318883.pdf [firstpage_image] =>[orig_patent_app_number] => 11812455 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6261965 [patent_doc_number] => 20100297022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'Magnetosome Gene Expression in Eukaryotic Cells' [patent_app_type] => utility [patent_app_number] => 12/303793 [patent_app_country] => US [patent_app_date] => 2007-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 10080 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297022.pdf [firstpage_image] =>[orig_patent_app_number] => 12303793 [rel_patent_id] =>[rel_patent_doc_number] =>)